#MTC26 Flex Pass: Plan Now, Save Later
Join us October 18–21, 2026, in Boston, for The MedTech Conference where the global medtech community comes together to connect, collaborate, and move the industry forward – and enjoy exclusive member…
My Profile
Member Center
Policy
Top Priorities
On behalf of our members, AdvaMed® works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
Your Featured Resources
AdvaMed® Advancements: Q1 2026 Report
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
AdvaMed® Comment Letter to FDA: Exemptions from Premarket Notification Requirements for Class II Devices
AdvaMed’s® comments on FDA’s 510(k) exemption framework for Class II devices and its impact on innovation and patient access.
2025 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2025 on behalf of our member companies and the patients they serve.
AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
AdvaMed® 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
Scott Whitaker Op-Ed: Medicare must keep pace with FDA-authorized breakthrough medical technologies
Medicare breakthrough medical technologies face delays between FDA authorization and coverage decisions, slowing patient access to innovation.
Additional Resources
#MTC26 Flex Pass: Plan Now, Save Later
Join us October 18–21, 2026, in Boston, for The MedTech Conference where the global medtech community comes together to connect, collaborate, and move the industry forward – and enjoy exclusive member…
AdvaMed® Advancements: Q1 2026 Report
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
AdvaMed® Comment Letter to FDA: Exemptions from Premarket Notification Requirements for Class II Devices
AdvaMed’s® comments on FDA’s 510(k) exemption framework for Class II devices and its impact on innovation and patient access.
2025 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2025 on behalf of our member companies and the patients they serve.
Discover More Resources
AdvaMed® members have access to our full library of industry resources.
You are not logged in to the AdvaMed Hub.
AdvaMed® Welcomes Senate Introduction of Bipartisan Medical Device Electronic Labeling Bill
Washington, D.C.—AdvaMed, the Medtech Association, the world’s biggest trade association representing medtech innovators, welcomed Senate introduction of the bipartisan Medical Device Electronic Labeling Act (S. 4519), which would allow medtech…
The MedTech Conference 2026: Where Medtech Does Business
The MedTech Conference, brings together the companies shaping the future of innovation. Hosted by AdvaMed®, The Medtech Association, #MTC26 gives companies a focused moment to connect, collaborate, and turn conversations…
Esperto Medical™ Receives ARPA-H SBIR Award to Develop Continuous Wearable Blood Pressure Monitor
IRVINE, Calif., April 28, 2026 /PRNewswire/ — Esperto Medical™ today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) award from the Advanced Research Projects Agency for Health…
Bright Uro Receives FDA Clearance for Glean® Abdominal Sensor
IRVINE, Calif., May 7, 2026 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that the…
Earlier Answers, Better Care: How Expanded Access to Alzheimer’s Testing Can Change Lives
Early Alzheimer’s blood tests are improving diagnosis, but access depends on policy. Learn how expanded Medicare coverage is changing patient outcomes.
i-GENTIC AI Expands GENIE to Enforce Full FDA Compliance Lifecycle for Life Sciences
PALO ALTO, CA, UNITED STATES, May 4, 2026 / EINPresswire.com / — Biopharma and medtech companies face a years-long process to get their products approved. Drug and device makers navigate a full…
IEEPA Tariff Refunds Summary – What MedTech Companies Need to Know
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
A Policy Win for Maternal Health Innovation Through FDA–CMS Collaboration
The United States faces a maternal health crisis demanding urgent action. The U.S. has the worst maternal outcomes among high income nations. Our maternal mortality rates far exceed peer countries’,…
The Insight Series: AI & Digital Health
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery.…
AdvaMed Commends Positive Step Toward Greater Medicare Coverage of Breakthrough Medtech
WASHINGTON—AdvaMed, the Medtech Association, the largest trade association representing medtech innovators, has long pressed for faster Medicare consideration of covering treatments using FDA-authorized breakthrough medtech. President and CEO Scott Whitaker made the…
Membership Newsletter
We are pleased to provide AdvaMed® members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.